Eeyarestatin 24 impairs SecYEG-dependent protein trafficking and inhibits growth of clinically relevant pathogens. (2021)
Attributed to:
The exploitation of mannosyltransferase inhibitors to modulate glycoprotein biogenesis and quality control
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/mmi.14589
PubMed Identifier: 32798330
Publication URI: http://europepmc.org/abstract/MED/32798330
Type: Journal Article/Review
Volume: 115
Parent Publication: Molecular microbiology
Issue: 1
ISSN: 0950-382X